Leonardo & SMi Webinar Invite: Adapting to the New Normal – Managing Cyber Risks to the Utilities Sector Beyond COVID-19
SMi Reports: A webinar on Adapting to the New Normal – Managing Cyber Risks to the Utilities Sector beyond COVID-19...
SMi Reports: A webinar on Adapting to the New Normal – Managing Cyber Risks to the Utilities Sector beyond COVID-19...
London, United Kingdom, May 29, 2020 --(PR.com)-- Jennifer Juan is celebrating the upcoming release of her brand new poetry collection,...
London, United Kingdom, May 29, 2020 --(PR.com)-- To help the hospitality industry better understand the dynamic trends and impact of...
In a recent public announcement, MerPerle Hon Tam Resort revealed the exciting news that Park Hang-Seo, Vietnam Football Squads Coach,...
HONG KONG--(BUSINESS WIRE)--YEAHKA LIMITED, China’s leading payment and business service technology platform commences trading on the Main Board of The...
Hackaroma is the world's first scent-inspired hackathon. It has decided six finalists for the next development round. Those six projects...
Tokyo, Japan, May 30, 2020 --(PR.com)-- Integrated Investment Research announced their start to the year earnings this week, with better...
HONG KONG--(BUSINESS WIRE)--ViaBTC Group, an innovative technology company specialized in blockchain and dedicated to providing users with comprehensive digital asset...
Investment from Aquiline and 83North will be used to continue rapid global expansion. Walldorf, Germany, May 29, 2020 --(PR.com)-- TIS...
Taipei, Taiwan, May 30, 2020 --(PR.com)-- Ares International Corp. was recently certified by International Swaps and Derivatives Association (ISDA) to...
LONDON--(BUSINESS WIRE)--#CrashBarrierSystemsMarket--The crash barrier systems market is expected to grow by USD 1.29 billion during 2020-2024. The report also provides...
Most non-critical pet care issues can be addressed & diagnosed online. An experienced veterinarian from Dr. Jacob Frydman Pet Care...
61.9% of patients with HER2 mutant metastatic non-small cell lung cancer treated with ENHERTU achieved a tumor response Breakthrough Therapy...
TOKYO & BASKING RIDGE, N.J. & MUNICH--(BUSINESS WIRE)--Results from the phase 2 DESTINY-CRC01 trial of Daiichi Sankyo Company, Limited (hereafter,...
Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation...